CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | Rider Michael J Global General Counsel | Grant or award | +4,474 | 10,918 | ||
| 2024-08-15 | Rider Michael J Global General Counsel | Grant or award | +476 | 11,394 | ||
| 2024-08-15 | Leong Justin Chief Product Officer | Grant or award | +8,259 | 27,000 | ||
| 2024-08-15 | Leong Justin Chief Product Officer | Grant or award | +878 | 27,878 | ||
| 2024-08-15 | Ghoshal Kaushik President, SaaS Business | Grant or award | +7,915 | 20,947 | ||
| 2024-08-15 | Ghoshal Kaushik President, SaaS Business | Grant or award | +841 | 21,788 | ||
| 2024-08-15 | Farrell Michael J. Chief Executive Officer | Grant or award | +19,272 | 460,071 | ||
| 2024-08-15 | Farrell Michael J. Chief Executive Officer | Grant or award | +4,098 | 464,169 | ||
| 2024-08-12 | Ghoshal Kaushik President, SaaS Business | Option exercise 10b5-1 | +2,086 | $95.80 | $200K | 15,118 |
| 2024-08-12 | Ghoshal Kaushik President, SaaS Business | Option exercise 10b5-1 | +6,877 | $95.80 | $659K | 21,995 |
| 2024-08-12 | Ghoshal Kaushik President, SaaS Business | Option exercise 10b5-1 | +1,037 | $101.64 | $105K | 23,032 |
| 2024-08-12 | Ghoshal Kaushik President, SaaS Business | Sale 10b5-1 | −10,000 | $216.60 | $2.2M | 13,032 |
| 2024-08-12 | Ghoshal Kaushik President, SaaS Business | Option exercise · ResMed Common Stock Options 10b5-1 | −2,086 | 0 | ||
| 2024-08-12 | Ghoshal Kaushik President, SaaS Business | Option exercise · ResMed Common Stock Options 10b5-1 | −6,877 | 0 | ||
| 2024-08-12 | Ghoshal Kaushik President, SaaS Business | Option exercise · ResMed Common Stock Options 10b5-1 | −1,037 | 9,260 | ||
| 2024-08-08 | Sandercock Brett Chief Financial Officer | Sale 10b5-1 | −1,000 | $212.16 | $212K | 89,056 |
| 2024-08-07 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +14,683 | $84.98 | $1.2M | 455,482 |
| 2024-08-07 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −14,683 | $214.25 | $3.1M | 440,799 |
| 2024-08-07 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −14,683 | 44,049 | ||
| 2024-08-05 | Leong Justin President, Asia Latin America | Sale | −48,000 | $217.07 | $10.4M | 18,741 |
Page 14 of 19 · 361 trades